comparemela.com

Kunzmannk Apellis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Keeping A Watchful Eye: Safety Reports in Geographic Atrophy Landscape

A headline year for retina disease drug development concurrently brought about research and discussion into the safety outcomes of these new agents.

United statesSan franciscoIapocec apellisDavid lallyKunzmannk apellisDilsher dhootVeeral shethIapocec charles wykoffCharles wykoffNathan steinleAvacincaptad pegolIapocec pegcetacoplanIapocec nathan steinleUniversity retinaApellis pharmaceuticalsMacula associates

FDA Approves Avacincaptad Pegol for Geographic Atrophy

The approval is the second granted to a geographic atrophy drug that targets the complement pathway.

United statesAvacincaptad pegolIapocec david lallyKunzmannk apellisAstellas pharmaDavid lallyArshadm khananiDrug administrationSierra eye associatesAmerican society of retina specialistsApellis pharmaceuticalsIveric bioAmerican societyRetina specialistsNew england retina consultantsNew treatment

vimarsana © 2020. All Rights Reserved.